These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21063489)

  • 1. Opposite effects of high and low doses of interleukin-2 on T cell-mediated hepatitis in mice (interleukin-2 on hepatitis).
    Zhang X; Wei HX; Rui S; Wei H; Tian Z
    Hepatol Int; 2010 Jul; 4(3):641-8. PubMed ID: 21063489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
    Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
    J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
    Li B; Sun R; Wei H; Gao B; Tian Z
    Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis.
    Yan S; Wang L; Liu N; Wang Y; Chu Y
    Immunol Cell Biol; 2012 Apr; 90(4):421-8. PubMed ID: 21691280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CpG ODN in concanavalin A-induced hepatitis in mice.
    Abe K; Ohira H; Kobayashi H; Rai T; Saito H; Takahashi A; Sato Y
    Fukushima J Med Sci; 2005 Jun; 51(1):41-9. PubMed ID: 16167672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.
    Louis H; Le Moine O; Peny MO; Quertinmont E; Fokan D; Goldman M; Devière J
    Hepatology; 1997 Jun; 25(6):1382-9. PubMed ID: 9185757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8
    Zhang Y; Qi C; Li L; Hua S; Zheng F; Gong F; Fang M
    Inflamm Res; 2019 Jan; 68(1):75-91. PubMed ID: 30430216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-11 reduces T-cell-dependent experimental liver injury in mice.
    Bozza M; Bliss JL; Maylor R; Erickson J; Donnelly L; Bouchard P; Dorner AJ; Trepicchio WL
    Hepatology; 1999 Dec; 30(6):1441-7. PubMed ID: 10573523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.
    Nakashima H; Kinoshita M; Nakashima M; Habu Y; Shono S; Uchida T; Shinomiya N; Seki S
    Hepatology; 2008 Dec; 48(6):1979-88. PubMed ID: 18942689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with propylene glycol alginate sodium sulfate ameliorated concanavalin A-induced liver injury by regulating the PI3K/Akt pathway in mice.
    Xu S; Wu L; Zhang Q; Feng J; Li S; Li J; Liu T; Mo W; Wang W; Lu X; Yu Q; Chen K; Xia Y; Lu J; Xu L; Zhou Y; Fan X; Guo C
    Life Sci; 2017 Sep; 185():103-113. PubMed ID: 28774703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emodin protects against concanavalin A-induced hepatitis in mice through inhibiting activation of the p38 MAPK-NF-κB signaling pathway.
    Xue J; Chen F; Wang J; Wu S; Zheng M; Zhu H; Liu Y; He J; Chen Z
    Cell Physiol Biochem; 2015; 35(4):1557-70. PubMed ID: 25792514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased T-cell mediated hepatic injury in concanavalin A-treated PLRP2-deficient mice.
    Ge W; Gao Y; Zhao Y; Yang Y; Sun Q; Yang X; Xu X; Zhang J
    Int Immunopharmacol; 2020 Aug; 85():106604. PubMed ID: 32428799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
    Wang J; Sun R; Wei H; Dong Z; Tian Z
    Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.
    Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S
    Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
    Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
    J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes.
    Jaruga B; Hong F; Sun R; Radaeva S; Gao B
    J Immunol; 2003 Sep; 171(6):3233-44. PubMed ID: 12960353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency.
    Di Marco R; Xiang M; Zaccone P; Leonardi C; Franco S; Meroni P; Nicoletti F
    Autoimmunity; 1999 Oct; 31(2):75-83. PubMed ID: 10680745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential effects of low dose and high dose concanavalin A on cytokine profile and their importance in liver injury.
    Xu X; Wei H; Dong Z; Chen Y; Tian Z
    Inflamm Res; 2006 Apr; 55(4):144-52. PubMed ID: 16807695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the Japanese herbal medicine 'Inchinko-to' (TJ-135) on concanavalin A-induced hepatitis in mice.
    Yamashiki M; Mase A; Arai I; Huang XX; Nobori T; Nishimura A; Sakaguchi S; Inoue K
    Clin Sci (Lond); 2000 Nov; 99(5):421-31. PubMed ID: 11052923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.